Business Description
![Roche Holding AG Roche Holding AG logo](https://static.gurufocus.com/logos/0C000008TT.png?14)
Roche Holding AG
NAICS : 325412
SIC : 2834
ISIN : US7711951043
Share Class Description:
RHHBY: ADRDescription
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.05 | |||||
Debt-to-EBITDA | 1.66 | |||||
Interest Coverage | 15.44 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.05 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.7 | |||||
3-Year EBITDA Growth Rate | -4.7 | |||||
3-Year EPS without NRI Growth Rate | -1 | |||||
3-Year FCF Growth Rate | 1.2 | |||||
3-Year Book Growth Rate | -4.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 4.25 | |||||
Future 3-5Y Total Revenue Growth Rate | 4 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 81.02 | |||||
9-Day RSI | 73.77 | |||||
14-Day RSI | 67.93 | |||||
6-1 Month Momentum % | -14.03 | |||||
12-1 Month Momentum % | -20.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 184.84 | |||||
Days Sales Outstanding | 70.15 | |||||
Days Payable | 85.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.01 | |||||
Dividend Payout Ratio | 0.49 | |||||
3-Year Dividend Growth Rate | 1.8 | |||||
Forward Dividend Yield % | 4.01 | |||||
5-Year Yield-on-Cost % | 4.56 | |||||
3-Year Average Share Buyback Ratio | 2.2 | |||||
Shareholder Yield % | 4.06 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.94 | |||||
Operating Margin % | 25.47 | |||||
Net Margin % | 19.02 | |||||
FCF Margin % | 18.93 | |||||
ROE % | 41.15 | |||||
ROA % | 13.12 | |||||
ROIC % | 18.37 | |||||
ROC (Joel Greenblatt) % | 60.53 | |||||
ROCE % | 24.48 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.59 | |||||
Forward PE Ratio | 13.6 | |||||
PE Ratio without NRI | 12.74 | |||||
Shiller PE Ratio | 17.43 | |||||
Price-to-Owner-Earnings | 17.03 | |||||
PEG Ratio | 10.62 | |||||
PS Ratio | 3.23 | |||||
PB Ratio | 6.57 | |||||
Price-to-Tangible-Book | 38.02 | |||||
Price-to-Free-Cash-Flow | 17 | |||||
Price-to-Operating-Cash-Flow | 12.1 | |||||
EV-to-EBIT | 14.11 | |||||
EV-to-Forward-EBIT | 11.25 | |||||
EV-to-EBITDA | 11.46 | |||||
EV-to-Forward-EBITDA | 9.77 | |||||
EV-to-Revenue | 3.5 | |||||
EV-to-Forward-Revenue | 3.58 | |||||
EV-to-FCF | 18.91 | |||||
Price-to-Projected-FCF | 1.21 | |||||
Price-to-DCF (Earnings Based) | 0.79 | |||||
Price-to-DCF (FCF Based) | 1.03 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
Price-to-Graham-Number | 4.68 | |||||
Earnings Yield (Greenblatt) % | 7.09 | |||||
FCF Yield % | 6.08 | |||||
Forward Rate of Return (Yacktman) % | 8.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RHHBY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Roche Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 68,490.408 | ||
EPS (TTM) ($) | 2.017 | ||
Beta | 0.56 | ||
Volatility % | 18.98 | ||
14-Day RSI | 67.93 | ||
14-Day ATR ($) | 0.490987 | ||
20-Day SMA ($) | 32.164 | ||
12-1 Month Momentum % | -20.95 | ||
52-Week Range ($) | 29.2 - 40.15 | ||
Shares Outstanding (Mil) | 6,377.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Roche Holding AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Roche Holding AG Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Roche Holding AG Frequently Asked Questions
What is Roche Holding AG(RHHBY)'s stock price today?
The current price of RHHBY is $33.46. The 52 week high of RHHBY is $40.15 and 52 week low is $29.20.
When is next earnings date of Roche Holding AG(RHHBY)?
The next earnings date of Roche Holding AG(RHHBY) is 2024-07-25.
Does Roche Holding AG(RHHBY) pay dividends? If so, how much?
The Dividend Yield %  of Roche Holding AG(RHHBY) is 4.01% (As of Today), Highest Dividend Payout Ratio of Roche Holding AG(RHHBY) was 0.59. The lowest was 0.43. And the median was 0.49. The  Forward Dividend Yield % of Roche Holding AG(RHHBY) is 4.01%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |